Women undergoing the menopausal transition may be prone to prolonged bleeding with periods of heaviness, according to a new study in BJOG.
Women undergoing the menopausal transition may be prone to prolonged bleeding with periods of heaviness, according to a new study in BJOG.
Researchers from the University of Michigan School of Public Health and the University of Michigan Health System looked at 1320 midlife women from a variety of races who had participated in the Study of Women’s Health Across the Nation Menstrual Calendar Substudy. Each woman completed a daily menstrual calendar from 1996 to 2006 that included information about hormone therapy, smoking status, and the level of physical activities. Height and weight were measured every year. Primary outcomes examined included menses of 10-plus days, spotting of 6-plus days, and heavy bleeding of 3-plus days. Multivariable regression and Kaplan-Meier survival analysis were used to analyze the data.
In the cohort, 77.7% (95% confidence interval [CI] 56.7-93.2) reported at least 3 occurrences of menses of 10-plus days. At least 3 occurrences of 6-plus days of spotting were reported by 66.8% (95% CI 55.2 – 78.0) of the women and 34.5% (95% CI 30.2 – 39.2) reported at least 3 occurrences of 3-plus days of heavy bleeding. Each primary outcome was associated with uterine fibroids, hormone use, and ethnicity. Body mass index was associated with 3-plus days of heavy bleeding.
The investigators concluded that the study provided important information about how frequent spotting, prolonged bleeding, and heavy bleeding can be during the menopausal transition. They felt the data could help facilitate clinical decision-making during that time.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Echogenic Mass identified as key predictor for retained products of conception
May 13th 2024Discover how recent findings highlight the significance of echogenic masses in accurately diagnosing post-pregnancy complications, shedding light on effective management strategies and reducing the need for invasive interventions.
Read More